XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,307 | -11.3% | 184,632 | +0.0% | 0.01% | 0.0% |
| Q2 2023 | $7,108 | +909.7% | 184,631 | +838.2% | 0.01% | +800.0% |
| Q1 2023 | $704 | +7.2% | 19,679 | +18.2% | 0.00% | 0.0% |
| Q4 2022 | $657 | -99.9% | 16,650 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $578,000 | +18.7% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $487,000 | +38.4% | 16,000 | +39.1% | 0.00% | – |
| Q1 2022 | $352,000 | +39.1% | 11,500 | +42.0% | 0.00% | – |
| Q4 2021 | $253,000 | – | 8,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |